Fluid Sample News Today : Breaking News, Live Updates & Top Stories | Vimarsana

round up, from the bbc sport centre. hello — thanks forjoining us. manchester united manager erik ten hag says he's expecting brighton to be out for revenge tonight. they only met ten days ago. when united won their fa cup semifinal on penalties. preventing brighton from getting to their first cup final in a0 years. they go again today — this time the prospect of european football being on the cards. brighton are 8th in the premier league — but with three games in hand, while united travel to the amex knowing a win could move them up to third, 7 points clear of fifth. if you ge...

new alzheimer's drug has - our historical responsibility. and a new alzheimer's drug has been i our historical responsibility. and a new alzheimer's drug has been shown to slow the disease by about one third. there are two days to go to the coronation of king charles and camilla the queen consort. the king will be the 40th monarch crowned at westminster abbey since 1066, and millions of people are expected watch the event in this country and around the world. final preparations are under way. our correspondent charlotte gallagher reports. two days to go, and the coronation campers ar...

Are working. find it and that is how these therapies are working-— are working. and how if it works, fantastic. people _ are working. and how if it works, fantastic. people need _ are working. and how if it works, fantastic. people need access i are working. and how if it works, fantastic. people need access to| are working. and how if it works, i fantastic. people need access to it? there are two main factors with this. it is $25,000 per person per yearfor the last one this. it is $25,000 per person per year for the last one reported on. these are going to be expensive drugs, that rules it...

Less of this amyloid inside it, and that's how these therapies are working. james, that's absolutely fascinating. and if it works, fantastic, but of course people have to have access to it. yeah, there are two massive problems here. so, the first one is going to be the cost. so we know how much this drug, the one from last year, it's about $25,000 per person per year. we don't know how much donanemab, the one that's been reported more recently, is going to cost, but these are going to be expensive drugs and that immediately rules it out for huge numbers of people all around the world. the seco...